Table 1 Baseline characteristics of study patients
Characteristics | Event group (n = 36) | Control group (n = 55) | P values |
|---|---|---|---|
Age , years, mean (standard deviation)a | 53.5 (13.8) | 54.4 (13.1) | 0.759 |
Male sex, n (%) | 29 (81) | 46 (84) | 0.781 |
Race, n (%) | |||
Caucasian | 34 (94) | 54 (98) | 0.560 |
Other | 2 (6) | 1 (2) | 0.560 |
Indication for cardiac transplantation, n (%) | |||
Coronary Artery Disease | 15 (42) | 18 (33) | 0.504 |
Idiopathic Cardiomyopathy | 14 (39) | 30 (55) | 0.198 |
Valvular Heart Disease | 2 (6) | 3 (5) | 1.000 |
Acute Myocarditis | 1 (3) | 2 (4) | 1.000 |
Congenital Heart Disease | 1 (3) | 0 (0) | 0.396 |
Other indications | 3 (8) | 3 (4) | 0.381 |
Use of ventricular assist device before transplantation, n (%) | 6 (17) | 13 (24) | 0.599 |
Induction therapy (any), n (%) | 28 (79) | 45 (82) | 0.784 |
Cytomegalovirus serology (IgG) status, n (%) | |||
Donor and Recipient Positive | 13 (36) | 13 (24) | 0.239 |
Donor and Recipient Negative | 7 (19) | 9 (16) | 0.781 |
Donor Positive and Recipient Negative | 3 (8) | 6 (11) | 1.000 |
Donor Negative and Recipient Positive | 6 (17) | 14 (25) | 0.439 |
Unknown | 7 (19) | 13 (24) | 0.797 |